抗ＦＧＦＲ２抗体と他剤を含む組成物

Title:

抗ＦＧＦＲ２抗体と他剤を含む組成物

Document Type and Number:

Japanese Patent JP6887944

Kind Code:

B2

Abstract:

A combination comprising an antibody capable of binding to human fibroblast growth factor receptor 2 (hFGFR2) and an agent that is different from the antibody.

More Like This:

WO/2024/040127	ANTI-TYRP1 BI-SPECIFIC T CELL ENGAGING PROTEIN FOR TREATMENT OF TYRP1-EXPRESSING MELANOMA
JP2014240438	METHODS AND COMPOSITIONS FOR TREATMENT OF ANTIBODY MEDIATED NEUROPATHIES
JP2003189873	PROPHYLACTIC/THERAPEUTIC AGENT FOR CANCER

Inventors:

Nonobu Shiose
Ishida Saori

Application Number:

JP2017511041A

Publication Date:

June 16, 2021

Filing Date:

April 07, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Daiichi Sankyo Co., Ltd.

International Classes:

A61K39/395; A61K31/4745; A61K33/243; A61P35/00

Domestic Patent References:

JP2012508184A
JP2015504434A

Foreign References:

WO2013154206A1

Other References:

Cancer Biology & Therapy,2010年,10(5),p.505-508
Cancer Research,2012年,72(8), Supp. SUPPL. 1,Abstract Number: 3758
Expert Opin.Biol.Ther.,2013年,13(8),p.1187-1196

Attorney, Agent or Firm:

Kimiki Ishibashi
Noriko Kitano
Toshiyasu Takemoto
Reiko Kanehara

Previous Patent: 鞍乗り型車両

Next Patent: セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー